Cardiawave SA: Cardiawave Confirms the Safety of VALVOSOFT its Non-Invasive Ultrasound Treatment for Aortic Stenosis
No cerebral vascular anomaly before and after treatment observed - Successful completion of the FIM II clinical study prior to the pivotal study, that will pave the way for CE marking Cardiawave SA
France General Benjamin Bertrand Kostenloser Wertpapierhandel James Palmer Professeur Emmanuel Messas Sophie Baratte
Source: finanznachrichten.de